Drug Topics

JULY 15, 2025

READ MORE: Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Drug Topics : How has the administration of insulin management been impacted by medical advancements in things like CGM and GLP-1 medications? Diana Isaacs: It's really interesting. Subscribe Now!

Insurance Coverage

Drug Topics

JUNE 6, 2025

2 Pharmacists can play a large role in the management of IBD, especially because medication nonadherence is common, leading to increased flares, hospitalizations, and complications. June 4, 2025. Accessed June 6, 2025. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Accessed June 6, 2025. Mayo Clinic.

FDA

Drug Topics

JULY 18, 2025

The Evolving Landscape of Insulin Delivery in Diabetes Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 17th 2025 Podcast Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.

Specialty Pharmacies

Drug Topics

JUNE 18, 2025

In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. The Mount Sinai Hospital. June 18, 2025. Accessed June 18, 2025. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. May 15, 2025.

Communication

Drug Topics

AUGUST 8, 2025

Nau, PhD, RPh, FAPhA Publication Article Drug Topics Journal Drug Topics July/August 2025 Volume 169 Issue 04 Colleges of pharmacy are retooling curricula and faculty skill sets to ensure students are prepared to use the technology of the next decade. Accessed June 1, 2025. April 18, 2025. Accessed June 4, 2025.

Specialty Pharmacies

Pharmacy Times

JULY 16, 2025

That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.

Vaccines

Pharmacy Times

AUGUST 6, 2025

Immunize.org.Updated July 3, 2025. Accessed July 16, 2025. Accessed July 16, 2025. Accessed July 16, 2025. The conversations grounded in pharmacy expertise and public health principles support healthier classrooms, stronger communities, and a more confident return to learning. REFERENCES 1. Vaccine-specific requirements.

Vaccines

Pharmacy Times

JUNE 20, 2025

Furthermore, an investigation conducted by Norwalk et al found significant differences between Black and non-Black populations in pneumococcal mortality and length of hospital stay. Racial disparities in adult pneumococcal vaccination indications and pneumococcal hospitalizations in the US. J Natl Med Assoc. 2019;111(5):540-545.

Vaccines

Pharmacy Times

JULY 25, 2025

Accessed July 23, 2025. Accessed July 23, 2025. Pneumococcal disease­­—pneumococcal vaccine recommendations. Last Updated October 26, 2024. CDC—AdultVaxView. Vaccination coverage among adults in the United States, National Health Interview Survey, 2022. Last Updated October 4, 2024. Hong K, Zhou F, Tsai Y, et al.

Vaccines

Pharmaceutical Technology

JUNE 25, 2025

June 25, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook BP is a chronic skin disease marked by severe itching, painful blisters, lesions and skin redness. In February 2025, the FDA accepted Dupixent’s supplemental biologics licence application (sBLA) for priority review. Credit: Toa55/Shutterstock.

FDA

Pharmaceutical Technology

AUGUST 11, 2025

Buy Reports Newsletters PT News FDA gives Arvinas and Pfizer’s vepdegestrant NDA for breast cancer Vepdegestrant is an investigational, oral bioavailable PROteolysis TArgeting Chimera (PROTAC) medication. Credit: Gorodenkoff/Shutterstock.com. Give your business an edge with our leading industry insights.

FDA

Drug Topics

JULY 18, 2025

The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. The FDA has approved a prefilled syringe format of the recombinant zoster vaccine Shingrix for the prevention of shingles, GSK said in a release. July 17, 2025. Accessed July 18, 2025.

Vaccines

The Checkup by Singlecare

MARCH 31, 2025

Ozempic and Wegovy (and Rybelsus , which is oral semaglutide) are GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists, commonly referred to as GLP-1s) and are the only FDA-approved drugs that contain the active ingredient semaglutide. Some facilities add B12 to their compounds, in addition to semaglutide.

Compounding

Drug Topics

JUNE 23, 2025

Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.

Community Pharmacies

Drug Topics

AUGUST 5, 2025

Investigators from Harvard Medical School and Brigham and Women’s Hospital conducted a study to compare the risk of cardiovascular events after starting treatment with individual sulfonylureas or DPP4 inhibitors. had an ischemic stroke, 3% had a heart failure hospitalization, and 0.4% July 24, 2025. Accessed August 5, 2025.

Specialty Pharmacies

Drug Topics

JULY 29, 2025

1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 Image Credit: Jesse B/peopleimages.com - stock.adobe.com In the study, eligible patients from Denmark who previously had 3 or more COVID-19 doses received the 2024-2025 JN.1 The study took place from May 1, 2024, to March 31, 2025. 1 booster vaccination. .

Vaccines

Pharmaceutical Technology

JULY 23, 2025

Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. EU’s Pharma Package falls short of Europe’s goal of global competitiveness Why can’t the US figure out weight loss drug prices?

Communication

Pharmaceutical Technology

JUNE 10, 2025

June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight. June 10, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Enflonsia is administered to infants with the same dose regardless of their bodyweight.

FDA

Pharmacy Times

JULY 16, 2025

The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.

HIV Treatment and Prevention Agents

Pharmacy Times

JULY 22, 2025

Importantly, Novavax received FDA approval in May 2025 with restrictions: It is approved for individuals 65 years and older and patients aged 12 to 64 years with at least 1 health condition that puts them at risk for severe COVID-19. If a patient has already received 1 dose, they are all set for the upcoming RSV season.

Vaccines

Pharmacy Times

JUNE 24, 2025

Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.

Compounding Pharmacies

Pharmacy Times

JULY 22, 2025

Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!

Compounding Pharmacies

Drug Topics

JULY 17, 2025

1 “Eligible outcomes included changes in health-related quality of life, medication adherence, hospitalization rates, inhalation techniques, or disease-related knowledge." " Finally, pharmacist-led interventions were all conducted in community pharmacies, outpatient clinics, or hospital settings. 2025; [link] 2.

Specialty Pharmacies

Drug Topics

AUGUST 8, 2025

1 READ MORE: Infections for Measles, Bird Flu, and Pertussis Increase in 2025 In China, where AMR is also on the rise, their systems for facilitating ASPs are complex and create difficulty for pharmacists and other providers to provide care. 2025 Jul 28;18:3735-3744. Accessed August 8, 2025. February 4, 2025.

Specialty Pharmacies

Pharmaceutical Technology

JUNE 12, 2025

GlobalData Healthcare June 12, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook European KOLs with cardiomyopathy patients told GlobalData that they are waiting for vutrisiran’s launch for ATTR-wt. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights.

Communication

Pharmacy Times

JULY 14, 2025

McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. SHOW MORE Dave’s Pharmacy in Alliance, Nebraska, was named the Pharmacy of the Year for cutting-edge patient care.

Independent Pharmacies

Pharmacy Times

JULY 2, 2025

The injection's room-temperature stability and compatibility with automated dispensing cabinets facilitate integration into hospital workflows. SHOW MORE The injection is indicated for the treatment of sepsis and other serious infections, enhancing treatment efficiency and patient care.

FDA

Pharmacy Times

AUGUST 5, 2025

Accessed June 10, 2025. Accessed June 10, 2025. Accessed June 10, 2025. Accessed June 10, 2025. Healthy People 2030. link] Flu vaccination coverage, United States, 2023-24 influenza season. September 20, 2024. link] FluVaxView. link] Brenan M. Nurses retain top ethics rating in U.S., but below 2020 high. January 10, 2023.

Vaccines

Pharmacy Times

AUGUST 1, 2025

Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025.

Specialty Pharmacies

Pharmacy Times

AUGUST 7, 2025

SHOW MORE The FDA intends to update opioid labels to highlight risks of addiction, overdose, and interactions, enhancing safety in pain management practices. 4 By integrating FDA's new labeling requirements and CDC's framework into daily practice, pharmacists can significantly lessen opioid risk.

Labelling

Pharmacy Times

JUNE 20, 2025

Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?

Compounding Pharmacies

Pharmaceutical Technology

JULY 30, 2025

July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. Credit: luchschenF/Shutterstock.com. Give your business an edge with our leading industry insights. Give your business an edge with our leading industry insights. Login Registration is disabled.

Packaging

Pharmacy Times

JUNE 24, 2025

In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).

Compounding Pharmacies

Drug Topics

JUNE 19, 2025

Image Credit: WindyNight - stock.adobe.com "Our findings showed that adolescents who received this combination therapy were able to improve many symptoms typically associated with insulin-managed type one diabetes,” Farid Mahmud, MD, FRCPC, physician at The Hospital for Sick Children, said in a news release. June 17, 2025.

Compounding

Drug Topics

JULY 24, 2025

The FDA approved delgocitinib (Anzupgo) cream for the treatment of moderate-to-severe chronic hand eczema (CHE) in adult patients, LEO Pharma announced in a release. 1 “We’re thrilled that the FDA recognizes the impact that moderate-to-severe [CHE] has on patients,” said Kristin Belleson, CEO and president of the National Eczema Association.

FDA

Pharmacy Times

JULY 22, 2025

Historically, the FDA has required preclinical testing in animals to obtain safety and efficacy data for investigational new drugs (INDs) before they can begin clinical testing in humans. 3 More simply, the FDA is moving preclinical testing from in vivo animal models to in silico and in vitro methods.

FDA

Pharmacy Times

JULY 12, 2025

At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.

Independent Pharmacies